EUVIMEDEUVIMED entdecken
Open Access

Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study

Rusha Bhandari iD, Yan Chen, Eric J Chow iD, Rebecca M Howell, Lisa B Kenney, Kevin R Krull iD, Wendy Leisenring iD, Paul C Nathan iD, Joseph P Neglia iD, Kirsten K Ness iD, Kevin C Oeffinger iD, Claire Snyder iD und 5 weitere

Journal of Clinical Oncology · 20.09.2025 · 43 (27) · 2998-3010

DOI: 10.1200/jco-25-00385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.09.2025. Verfasst von Rusha Bhandari und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Sciences, City of Hope, Duarte, CA. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE There are limited data on the risk for mortality and health outcomes among the increasing population of older (age >50 years) survivors of childhood cancer during this later stage in life when there is an expected increase in aging-related morbidities. METHODS We assessed cause-specific mortality, incident new cancers, chronic health conditions (CHCs), frailty, and health status among survivors from the Childhood Cancer Survivor Study, conditional on surviving to 50 years. We calculated conditional survival rates, standardized mortality ratios (SMRs), and, for incident new cancers, cumulative burden, standardized incidence ratios (SIRs), and relative rates (RRs), compared with the general US population. RRs for CHCs and prevalence ratios for frailty and health status outcomes were calculated for survivors compared with siblings. Piecewise exponential regression identified risk factors. RESULTS Among 7,490 childhood cancer survivors alive at age 50 years, subsequent 5-, 10-, and 15-year mortality risks were 8%, 18%, and 32%, respectively; overall SMR was 3.2 (95% CI, 3.0 to 3.4). SMRs were highest for death due to new cancer (SMR = 4.7; 95% CI, 4.2 to 5.2). In subset analysis, survivors without radiation therapy (RT) exposure had similar new cancer rates as the general population. The population attributable fraction of new cancers to RT was 40%. Survivors had >2-fold risk of severe, life-threatening, or fatal CHCs (any: RR, 2.6 [95% CI, 2.2 to 3.1]; multiple: RR, 3.3 [95% CI, 2.5 to 4.4]), specifically among survivors with history of RT exposure, compared with siblings. We identified no associations between chemotherapy and late health outcomes. CONCLUSION Older survivors of childhood cancer continue to have an elevated burden of premature mortality, new cancers, and adverse health outcomes as they age. The increased risk for cancer and CHCs among these older survivors is associated with RT, but not chemotherapy, exposure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsNeoplasmsHumansMaleFemaleMiddle AgedChildAdolescentAdultUnited StatesRisk FactorsYoung AdultHealth StatusChild, PreschoolIncidenceFrailtyAge Factors

Autor:innen und Institutionen

  • Department of Population Sciences, City of Hope, Duarte, CA.
  • Department of Pediatrics, City of Hope, Duarte, CA.
  • Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN.
  • Clinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, WA.
  • Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA.

ORCID-Profile: Rusha Bhandari, Eric J Chow, Kevin R Krull, Wendy Leisenring, Paul C Nathan, Joseph P Neglia, Kirsten K Ness, Kevin C Oeffinger, Claire Snyder, Lucie M Turcotte, F Lennie Wong, Yutaka Yasui, Saro H Armenian

Förderung

  • NCI NIH HHS

Zitieren

APA

Bhandari, R., Chen, Y., Chow, E. J., Howell, R. M., Kenney, L. B., Krull, K. R., Leisenring, W., Nathan, P. C., Neglia, J. P., Ness, K. K., Oeffinger, K. C., Snyder, C., Turcotte, L. M., Wong, F. L., Yasui, Y., Armstrong, G. T., & Armenian, S. H. (2025). Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 43(27), 2998-3010. https://doi.org/10.1200/jco-25-00385

Vancouver

Bhandari R, Chen Y, Chow EJ, Howell RM, Kenney LB, Krull KR, et al. Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 2025;43(27):2998-3010. doi:10.1200/jco-25-00385

BibTeX
@article{Bhandari2025,
  author = {Bhandari, Rusha and Chen, Yan and Chow, Eric J and Howell, Rebecca M and Kenney, Lisa B and Krull, Kevin R and Leisenring, Wendy and Nathan, Paul C and Neglia, Joseph P and Ness, Kirsten K and Oeffinger, Kevin C and Snyder, Claire and Turcotte, Lucie M and Wong, F Lennie and Yasui, Yutaka and Armstrong, Gregory T and Armenian, Saro H},
  title = {Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study},
  journal = {Journal of Clinical Oncology},
  year = {2025},
  volume = {43},
  number = {27},
  pages = {2998--3010},
  doi = {10.1200/jco-25-00385}
}
Kostenlos starten →